Jitendra Singh unveils India’s first CRISPR-based gene therapy for sickle cell disease
The breakthrough marks the country’s entry into advanced gene-editing therapeutics, an area so far dominated by a handful of global companies.
The breakthrough marks the country’s entry into advanced gene-editing therapeutics, an area so far dominated by a handful of global companies.
US scientists have developed a new CRISPR toolkit to boost the treatment of genetic disorders.
CRISPR-Cas, which functions like molecular "scissors", allows for precise alterations to the genomes of living organisms.
The subject of molecular biosciences is full of novel research prospects in areas of modern medicine, solar and biofuel production.
